Search

everythinglearnresearchcommunity

for

Search:↓

The article concludes that a thorough diagnosis and treatment plan, including medications, non-invasive methods, or surgery, is important for managing hair loss, with a combination of minoxidil and finasteride being particularly effective.

Men are increasingly seeking quick-result cosmetic treatments for their thicker, oilier skin and hair loss issues.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

Finasteride safely and effectively treats male pattern hair loss, but may cause reversible sexual issues and harm male fetuses.

Finasteride and minoxidil are effective for hair loss, but continued research is needed for better treatments.

Myo-inositol supplements may improve insulin sensitivity and help with conditions like PCOS and gestational diabetes, but more research is needed.

Finasteride effectively treats baldness but may cause sexual side effects.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

Hair ages due to genetics and environmental factors, leading to graying and thinning, with treatments available for some conditions.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Hormones and genetics affect hair growth and patterns, with some changes reversible and others not.

SHBG may be a useful early indicator and treatment target for PCOS.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Menopause significantly reduces skin collagen, leading to thinner, less elastic skin, and hormone replacement may help but requires careful consideration.

Minoxidil helps regrow hair in female pattern hair loss, but more research needed for other treatments.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Finasteride effectively treats male hair loss, improving growth and density.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

Aging scalp skin contributes to hair aging and loss, and more research is needed to develop better hair loss treatments.

Hair loss in postmenopausal woman caused by ovarian issue.

Primary care for PCOS focuses on lifestyle changes, medication based on symptoms, and mental health, with diabetes screening and specialist referral for severe cases.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Some nonsurgical hair loss treatments are effective, especially if started early.

The oral contraceptive ethinylestradiol/chlormadinone acetate is effective in reducing acne and improving other skin conditions related to high androgen levels.